Cargando…
Exploiting gene dependency to inform drug development for multiple myeloma
Despite recent advances in therapy, multiple myeloma essentially remains an incurable malignancy. Targeting tumour-specific essential genes, which constitute a druggable dependency, potentially offers a strategy for developing new therapeutic agents to treat MM and overcome drug resistance. To explo...
Autores principales: | Went, Molly, Hoang, Phuc H., Law, Philip J., Kaiser, Martin F., Houlston, Richard S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325789/ https://www.ncbi.nlm.nih.gov/pubmed/35882937 http://dx.doi.org/10.1038/s41598-022-16940-7 |
Ejemplares similares
-
Mutational processes contributing to the development of multiple myeloma
por: Hoang, Phuc H., et al.
Publicado: (2019) -
Regions of homozygosity as risk factors for multiple myeloma
por: Went, Molly, et al.
Publicado: (2019) -
Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms
por: Hoang, Phuc H., et al.
Publicado: (2018) -
Multiple mechanisms can disrupt oncogenic pathways in multiple myeloma
por: Hoang, Phuc H., et al.
Publicado: (2018) -
Impact of mitochondrial DNA mutations in multiple myeloma
por: Hoang, Phuc H., et al.
Publicado: (2020)